newsfilter
← Latest News
Business Wire·

Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors

Humanigen, Inc. (NASDAQ:HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,' announced today that the Company's Board of Directors (the "Board") has electe